# Anthera Pharmaceuticals Inc — Form D/A

Anthera Pharmaceuticals Inc of HAYWARD, CA, a company, filed a Form D amendment with the SEC on 2018-01-11. The offering totals $15.0M, of which $15.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2018-01-11
- Form: D/A
- Accession: 0001316175-18-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $15.0M
- Amount sold: $15.0M
- Investors: 21
- Date of first sale: 2017-10-27
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-298435

## Issuer

- Name: Anthera Pharmaceuticals Inc
- CIK: 0001316175
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 25801 INDUSTRIAL BOULEVARD, SUITE B, HAYWARD, CA, 94545
- Phone: (510) 856-5600

## Officers, directors & promoters (1)

| Name | Role | Location |
| --- | --- | --- |
| May Liu | Executive Officer | Hayward, CA |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2017-11-09](https://search.stillhousedata.com/formd/0001316175-17-000001) | D | $2.9M | $2.9M |

## More

- [CIK 1316175 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1316175&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001316175-18-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.